Arrayjet Ltd is a leading Bioprinting & CRO/CMO providing innovative solutions to researchers, drug development groups and diagnostic companies world-wide.

With significant microarraying experience and instrument installations in 28 countries globally, Arrayjet offers reliable consultative support and a well-proven technology.

Whether printing onto slides, microplates or custom biochips, Arrayjet’s platform uses unique, non-contact, inkjet printing to offer unrivalled throughput, precision, and consistency that delivers high quality, reproducible microarrays faster than any other technology.

Through the provision of Arrayjet Advance in-house printing service, high-throughput screening programmes are possible: from examining host-pathogen interactions to epitope mapping, cancer and autoimmune biomarker identification, drug discovery, hybridoma screening and antibody validation.

A range of five scaleable instruments are custom-built on-site, offering solutions from R&D through to full manufacturing capabilities.